Proactiveinvestors USA & Canada MindMed https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada MindMed RSS feed en Wed, 02 Dec 2020 17:11:46 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) MindMed launches digital medicine division Albert to weave together technology and psychedelics https://ca.proactiveinvestors.com/companies/news/934788/mindmed-launches-digital-medicine-division-albert-to-weave-together-technology-and-psychedelics-934788.html Tue, 24 Nov 2020 13:56:00 -0500 https://ca.proactiveinvestors.com/companies/news/934788/mindmed-launches-digital-medicine-division-albert-to-weave-together-technology-and-psychedelics-934788.html MindMed reports a current cash position of C$50.1M https://ca.proactiveinvestors.com/companies/news/934066/mindmed-reports-a-current-cash-position-of-c501m-934066.html Mon, 16 Nov 2020 14:27:00 -0500 https://ca.proactiveinvestors.com/companies/news/934066/mindmed-reports-a-current-cash-position-of-c501m-934066.html MindMed wraps up Phase 1 LSD study in partnership with Swiss lab; prepares for Phase 2 of 'Project Lucy' https://ca.proactiveinvestors.com/companies/news/932949/mindmed-wraps-up-phase-1-lsd-study-in-partnership-with-swiss-lab-prepares-for-phase-2-of--project-lucy--932949.html Mon, 02 Nov 2020 14:27:00 -0500 https://ca.proactiveinvestors.com/companies/news/932949/mindmed-wraps-up-phase-1-lsd-study-in-partnership-with-swiss-lab-prepares-for-phase-2-of--project-lucy--932949.html MindMed Inc. looks to up-list to the Nasdaq amidst rise in popularity of psychedelic medicines https://ca.proactiveinvestors.com/companies/news/930926/mindmed-inc-looks-to-up-list-to-the-nasdaq-amidst-rise-in-popularity-of-psychedelic-medicines-930926.html Wed, 07 Oct 2020 18:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/930926/mindmed-inc-looks-to-up-list-to-the-nasdaq-amidst-rise-in-popularity-of-psychedelic-medicines-930926.html Mind Medicine to commit $5M to launch and develop clinical training program in field of psychedelic therapies and medicine https://ca.proactiveinvestors.com/companies/news/930665/mind-medicine-to-commit-5m-to-launch-and-develop-clinical-training-program-in-field-of-psychedelic-therapies-and-medicine-930665.html Mon, 05 Oct 2020 17:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/930665/mind-medicine-to-commit-5m-to-launch-and-develop-clinical-training-program-in-field-of-psychedelic-therapies-and-medicine-930665.html MindMed announces R&D collaboration with Liechti Lab in Switzerland on psilocybin https://ca.proactiveinvestors.com/companies/news/929913/mindmed-announces-rd-collaboration-with-liechti-lab-in-switzerland-on-psilocybin-929913.html Thu, 24 Sep 2020 13:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/929913/mindmed-announces-rd-collaboration-with-liechti-lab-in-switzerland-on-psilocybin-929913.html MindMed announces first-ever clinical trial combining MDMA and LSD https://ca.proactiveinvestors.com/companies/news/927471/mindmed-announces-first-ever-clinical-trial-combining-mdma-and-lsd-927471.html Tue, 25 Aug 2020 12:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/927471/mindmed-announces-first-ever-clinical-trial-combining-mdma-and-lsd-927471.html MindMed ends 2Q with US$24 million in cash to fund clinical trials on psychedelic substances https://ca.proactiveinvestors.com/companies/news/926737/mindmed-ends-2q-with-us24-million-in-cash-to-fund-clinical-trials-on-psychedelic-substances-926737.html Fri, 14 Aug 2020 14:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/926737/mindmed-ends-2q-with-us24-million-in-cash-to-fund-clinical-trials-on-psychedelic-substances-926737.html MindMed expanding R&D presence in Europe with Dr Miri Halperin Wernli leading the charge https://ca.proactiveinvestors.com/companies/news/926640/mindmed-expanding-rd-presence-in-europe-with-dr-miri-halperin-wernli-leading-the-charge-926640.html Thu, 13 Aug 2020 15:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/926640/mindmed-expanding-rd-presence-in-europe-with-dr-miri-halperin-wernli-leading-the-charge-926640.html MindMed engages renowned psychedelic-assisted therapy expert Dr Peter Gasser as an advisor to its LSD experiential therapy program Project Lucy https://ca.proactiveinvestors.com/companies/news/926026/mindmed-engages-renowned-psychedelic-assisted-therapy-expert-dr-peter-gasser-as-an-advisor-to-its-lsd-experiential-therapy-program-project-lucy-926026.html Thu, 06 Aug 2020 12:08:00 -0400 https://ca.proactiveinvestors.com/companies/news/926026/mindmed-engages-renowned-psychedelic-assisted-therapy-expert-dr-peter-gasser-as-an-advisor-to-its-lsd-experiential-therapy-program-project-lucy-926026.html MindMed seeks to harvest the power of psychedelics to treat mental health disorders https://ca.proactiveinvestors.com/companies/news/924866/mindmed-seeks-to-harvest-the-power-of-psychedelics-to-treat-mental-health-disorders-924866.html Thu, 30 Jul 2020 11:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/924866/mindmed-seeks-to-harvest-the-power-of-psychedelics-to-treat-mental-health-disorders-924866.html MindMed says dosing concluded in Phase 1 study of its 18-MC molecule which was well tolerated in humans https://ca.proactiveinvestors.com/companies/news/925255/mindmed-says-dosing-concluded-in-phase-1-study-of-its-18-mc-molecule-which-was-well-tolerated-in-humans-925255.html Tue, 28 Jul 2020 12:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/925255/mindmed-says-dosing-concluded-in-phase-1-study-of-its-18-mc-molecule-which-was-well-tolerated-in-humans-925255.html MindMed building diverse pipeline and leadership position in psychedelic inspired medicines industry https://ca.proactiveinvestors.com/companies/news/922991/mindmed-building-diverse-pipeline-and-leadership-position-in-psychedelic-inspired-medicines-industry-922991.html Mon, 29 Jun 2020 13:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/922991/mindmed-building-diverse-pipeline-and-leadership-position-in-psychedelic-inspired-medicines-industry-922991.html MindMed files patents for technologies to optimize and personalize psychedelic dosing regimens https://ca.proactiveinvestors.com/companies/news/922667/mindmed-files-patents-for-technologies-to-optimize-and-personalize-psychedelic-dosing-regimens-922667.html Wed, 24 Jun 2020 13:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/922667/mindmed-files-patents-for-technologies-to-optimize-and-personalize-psychedelic-dosing-regimens-922667.html MindMed investigating potential benefits of DMT in upcoming Phase 1 clinical trial collaboration https://ca.proactiveinvestors.com/companies/news/922367/mindmed-investigating-potential-benefits-of-dmt-in-upcoming-phase-1-clinical-trial-collaboration-922367.html Fri, 19 Jun 2020 15:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/922367/mindmed-investigating-potential-benefits-of-dmt-in-upcoming-phase-1-clinical-trial-collaboration-922367.html MindMed to collaborate on study of DMT intravenous dosing regimens with Swiss research partner https://ca.proactiveinvestors.com/companies/news/922236/mindmed-to-collaborate-on-study-of-dmt-intravenous-dosing-regimens-with-swiss-research-partner-922236.html Thu, 18 Jun 2020 12:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/922236/mindmed-to-collaborate-on-study-of-dmt-intravenous-dosing-regimens-with-swiss-research-partner-922236.html MindMed looks to psychedelic medicines to help curb the post-coronavirus mental health crisis https://ca.proactiveinvestors.com/companies/news/921948/mindmed-looks-to-psychedelic-medicines-to-help-curb-the-post-coronavirus-mental-health-crisis-921948.html Tue, 16 Jun 2020 06:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/921948/mindmed-looks-to-psychedelic-medicines-to-help-curb-the-post-coronavirus-mental-health-crisis-921948.html MindMed collaborating on Phase 2 clinical trial evaluating LSD to treat cluster headaches at Swiss lab https://ca.proactiveinvestors.com/companies/news/921356/mindmed-collaborating-on-phase-2-clinical-trial-evaluating-lsd-to-treat-cluster-headaches-at-swiss-lab-921356.html Mon, 08 Jun 2020 13:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/921356/mindmed-collaborating-on-phase-2-clinical-trial-evaluating-lsd-to-treat-cluster-headaches-at-swiss-lab-921356.html MindMed takes another step forward adding MDMA to their R&D pipeline https://ca.proactiveinvestors.com/companies/news/921301/mindmed-takes-another-step-forward-adding-mdma-to-their-rd-pipeline-921301.html Fri, 05 Jun 2020 21:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/921301/mindmed-takes-another-step-forward-adding-mdma-to-their-rd-pipeline-921301.html MindMed launches drug development program Project Lucy to treat anxiety disorders with LSD https://ca.proactiveinvestors.com/companies/news/921179/mindmed-launches-drug-development-program-project-lucy-to-treat-anxiety-disorders-with-lsd-921179.html Thu, 04 Jun 2020 14:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/921179/mindmed-launches-drug-development-program-project-lucy-to-treat-anxiety-disorders-with-lsd-921179.html MindMed adds new principal investigator and Swiss trial site as it expands Phase 2 study of microdosing LSD for adult ADHD https://ca.proactiveinvestors.com/companies/news/920952/mindmed-adds-new-principal-investigator-and-swiss-trial-site-as-it-expands-phase-2-study-of-microdosing-lsd-for-adult-adhd-920952.html Tue, 02 Jun 2020 17:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/920952/mindmed-adds-new-principal-investigator-and-swiss-trial-site-as-it-expands-phase-2-study-of-microdosing-lsd-for-adult-adhd-920952.html MindMed aims to curb opioid abuse and treat ADHD patients with its psychedelic inspired medicines https://ca.proactiveinvestors.com/companies/news/918093/mindmed-aims-to-curb-opioid-abuse-and-treat-adhd-patients-with-its-psychedelic-inspired-medicines-918093.html Fri, 24 Apr 2020 14:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/918093/mindmed-aims-to-curb-opioid-abuse-and-treat-adhd-patients-with-its-psychedelic-inspired-medicines-918093.html